VivoSeq
Other

Premedication

0

Pipeline Programs

6

Active Trials

0

Companies Involved

Premedication is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

97/100

Attrition Rate

2/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

56

clinical trials

Completed36 · 64%
Unknown status13 · 23%
Recruiting5 · 9%
Withdrawn1 · 2%
Active, not recruiting1 · 2%

Trial Activity

56 trials

Effect of Premedication With Pronase on Mucosal Cleanliness During EGD
Recruiting··N/A·NCT06713421·3,000 enrolled
The Effects of Gabapentin Premedication on Neurosurgery
Completed··N/A·NCT02306278·122 enrolled
Reassessment of Premedication in Surgery
Completed·UUniversity Hospital, Angers·Phase 4·NCT01549691·455 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)